“borderline significant”

When comparing the AUCs of MELD-Na and the ML model, we observed a statistically borderline significant difference ( p = 0.05).

In the full model, COVID-19 was borderline significant ( p = 0.05), while age was highly significant ( p < 0.01).

Improvement in work and social functioning was borderline significant (mean change −2.92, Hedges g = 0.28; P = 0.05).

Figure 4 , A, confirmed a statistically significant association between maximum Pa o 2 and death (Wald χ 2 = 8.72, df = 3, P = .033) and borderline significant nonlinearity (Wald χ 2 = 5.81, df = 2, P = .05).

However, the Asian population exhibited a borderline significant association with this polymorphism (OR = 0.725, 95% CI = 0.525–1.000, p = 0.050) (Fig. 3 ).

During almost 20 years of follow-up across all IJD categories, OI occurred more often in RA (17.9%) than PsA (12.6%) or AS patients (13.3%) ( p = 0.002) with a significantly higher overall OI incidence rate in RA patients than in PsA and AS patients (both p < 0.01) while the rate difference between PsA and AS was borderline significant ( p = 0.05) (Table 2 ).

In the parsimonious model, HPV18 positivity remained borderline significant (adjusted OR = 4.17, 95% CI: 1.00–16.97; p = 0.050.

Post-race right ventricular (RV) dysfunction with reduced strain and increased volumes ( p < 0.05) and borderline significant left ventricular global longitudinal strain reduction ( p = 0.05) were observed.

Subgroup analyses focusing on terpenoids revealed a borderline significant improvement in ADAS-cog scores following supplementation (SMD = −2.20, 95% CI −4.34 to −0.06, t 5 = −2.65, p = 0.05) ( Figure 5 ), although substantial heterogeneity was observed ( I 2 = 98%, p < 0.01).

However, higher cIMT at baseline had a borderline significant association with higher LVDF at follow-up ( p = 0.05). 3.4.

Nuclear MMP9 expression correlated with ACR and immune cell markers and was borderline significant for AMR ( p ≈ 0.05).

Metastasis status also showed a borderline significant association with NLR levels (p = 0.050), with a higher proportion of metastatic cases observed in the high NLR group.

Acute lower respiratory symptoms were associated with lower CCL17 [estimate: 0.6 pg/ml, (95% CI: 0.5–0.8), p < 0.001] and a borderline significant lower level of CCL20 [estimate: 0.5 pg/ml (95% CI: 0.2–1.0), p = 0.05] ( Table 4 ).

This result was borderline significant ( p = 0.05), and therefore should be interpreted with caution, as it may reflect a trend rather than a definitive difference.

However, the composite outcome of death or BPD was only borderline significant (40.0% vs. 46.3%, p = 0.05), and mortality alone was numerically higher in the budesonide group (16.9% vs. 13.6%, RR 1.24), although not statistically significant [ 40 ].

A borderline significant relationship was found between LSM and age ( r = .34; P = .05).

One study reported that IPSS-R outperformed IPSS in predicting OS [ 44 ], with a C-index of 0.74 ( p < 0.001), and showed borderline significant superiority over WPSS ( p = 0.05), although no significant differences were found for PFS prediction.

Overall time had a borderline significant difference ( p = 0.05) for patients with a Q12-16 response (Table 3 , Fig. 5 ).

When using weight gain between six and 12 months and BMI as continuous variables, the same pattern was seen, except for only a borderline significant association in the multivariable version (βeta ( β ) 0.048, (SE), 0.025, p = 0.05).

Associations Between Histological Parameters and OVT on Broiler Level On broiler level, a linear mixed model revealed a significant association between the OVT concentration and the villus length ( P = 0.044) and a borderline significant association between the OVT concentration and the villus-to-crypt ratio ( P = 0.050) ( Figure 3 ).

There was a borderline significant relationship between higher levels of donor INS ‐cfDNA and lower islet yield [−0.38 (0.18), p = .050] (Table 2 ).

Linear Mixed Modelling reported a borderline significant improvement in Processing Speed (t = 1.98, p =.05) for the methylphenidate group.

This also appeared to be the case for women with a family history of breast cancer; however, the association was only borderline significant (OR = 0.87, 95% CI [0.76-1.00], p = 0.05) (Table 2 ).

While the use of corticosteroids showed a borderline significant benefit (MD = 1.34, 95% CI: 0.01–2.67, p = 0.05), ALA supplementation did not significantly enhance olfactory recovery (MD = 0.50, 95% CI: −0.07–1.07, p = 0.08).

A borderline significant increase was recorded in target segment revascularization with FFR in the RCA (adjusted HR, 1.46; 95% CI, 1.00-2.15; P = .05).